Surgical marking composition and method

• US 20050255045A1
• Filed: 05/13/2004
• Published: 11/17/2005
• Est. Priority Date: 05/13/2004
• Status: Abandoned Application

• Current Assignee: US Department of Veterans Affairs (Government of the United States of America), Board of Supervisors of Louisiana State University Agricultural & Mechanical College (Louisiana State University System)
• Original Assignee: US Department of Veterans Affairs (Government of the United States of America), Board of Supervisors of Louisiana State University Agricultural & Mechanical College (Louisiana State University System)
• Inventors: Woltering, Eugene A.
• Application Number:
  US10/845,279
• Publication Number:
  US 20050255045A1
• Time in Patent Office: Days
• US Class Current: 424/9.340
• CPC Class Codes: A61K 49/0447 Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound

Abstract

A surgical marking system has been developed that can be easily used during surgery to mark an area of the body, e.g., the margins of a tumor resection cavity, for post-operative radiation therapy or subsequent evaluation by CT, MRI, or radiography. This marker system is formed as a semi-liquid solution that is expelled into the resection margins as a stream that quickly polymerizes in situ into a solid or semi-solid strand that adheres to the surrounding tissue. Several of these strands may be placed to outline the cavity surface. One or more of the polymerizing agents contain one or more imageable markers for post-operative imaging or therapy. The method allows a surgeon to outline the margins of a surgical site in all directions. In addition, radioactive isotopes or therapeutic drugs can be added to the marker strands for in situ therapy.

Claims

1. A kit comprising a first composition, a second composition, a marker, and a mixer;

wherein;

(a) neither said first composition alone, nor said second composition alone, readily polymerizes under ambient conditions;

(b) said mixer comprises compartments that are adapted to hold a first liquid and a second liquid, and to keep the first and second liquids separate from each other; and

then, at a time selected by the user, to mix at least some of the first liquid with at least some of the second liquid, and to extrude the resulting mixture;

(c) the first liquid comprises said first composition, or the first liquid comprises said first composition mixed with a first solvent; and

the second liquid comprises said second composition, or the second liquid comprises said second composition mixed with a second solvent;

wherein the first and second solvents may be the same or different;

(d) the first liquid comprises said marker;

or the second liquid comprises said marker;

or said mixer comprises compartments to hold the marker separate from the first and second liquids, and then to mix said marker with the first and second liquids;

whereby, the mixture extruded by said mixer comprises said marker;

(e) the extruded mixture is initially liquid, but polymerizes into a hardened solid or semi-solid over a period between about 10 seconds and about 180 seconds after extrusion;

(f) the extruded mixture, when liquid, will adhere to living tissue; and

after hardening, will stay adhered to the tissue for a period between about two weeks and about five years;

but the extruded mixture is ultimately biodegradable after the passage of sufficient time;

(g) the first composition, the second composition, and the marker are all sterilized, and are all substantially free from pathogens;

(h) the extruded mixture, when hardened, is nonpyrogenic and nontoxic; and

(i) said marker substantially enhances imaging of the hardened, extruded mixture as compared to the imaging that is otherwise obtainable for the tissue to which the mixture adheres;

by at least one imaging technique.

2. A kit as recited in claim 1, wherein said imaging technique is selected from the group consisting of radiography, autoradiography, computed tomography, fluoroscopy, ultrasound, Doppler, magnetic resonance imaging, and an optical detector of activated flourescein.

3. A kit as recited in claim 1, wherein said first composition comprises albumin and said second composition comprises glutaraldehyde.

4. A kit as recited in claim 1, wherein said first composition additional comprises a plasticizer, or said second composition additionally comprises a plasticizer.

5. A kit as recited in claim 4, wherein said plasticizer is glycerol.

6. A kit as recited in claim 1, wherein said first composition comprises thrombin and said second composition comprises fibrinogen.

7. A kit as recited in claim 1, wherein said first composition comprises a branched thermoplastic polymer and said second composition comprises a polymerizing solvent.

8. A kit as recited in claim 1, wherein the extruded mixture polymerizes into a hardened solid over a period between about 30 seconds and about 120 seconds after extrusion.

9. A kit as recited in claim 1, wherein the extruded mixture polymerizes into a hardened solid over a period between about 30 seconds and about 60 seconds after extrusion.

10. A kit as recited in claim 1, wherein said marker is selected from the group consisting of a radioactive isotope, iodine, titanium, gadolinium, stainless steel, a fluorescent compound, flourescein, a salt of another high-atomic number metal, or a powder of another high- atomic number metal.

11. A kit as recited in claim 1, wherein said marker comprises iodine.

12. A kit as recited in claim 1, wherein said marker comprises gadolinium.

13. A kit as recited in claim 1, wherein said marker comprises gadolinium and iodine.

14. A kit as recited in claim 1, wherein said mixer is adapted to extrude said mixture in multiple streams simultaneously.

15. A kit as recited in claim 1, wherein said first composition or said second composition additionally comprises boron cages.

16. A kit as recited in claim 1, wherein said first composition or said second composition additionally comprises one or more biologically active agents.

17. A kit as recited in claim 16, wherein said biologically active agent is selected from the group consisting of anti-infective, antibacterial, antimicrobial, antifungal, antiviral, anti-parasitic, anti-inflammatory, anti-angiogenic, analgesic and cytotoxic agents, beneficial hormones or other peptides, and other biologic response modifiers.

18. A method for marking the location of a surgically-exposed area in the interior of living tissue, said method comprising applying an extruded liquid mixture produced by the kit of claim 1 to at least a portion of the area, and allowing the extruded mixture to adhere to and harden upon the tissue;

whereby the marker within the hardened mixture will allow the location to be imaged even after the once surgically-exposed area has been closed.

19. A method as recited in claim 18, wherein the margins of a resection cavity in tissue are marked with a network of the extruded mixture.

20. A method as recited in claim 19, wherein the resection cavity is a tumor resection cavity.

21. A method as recited in claim 19, wherein the resection cavity is not filled with the extruded mixture, but the instead is marked only on the periphery of the cavity.

22. A method as recited in claim 18, wherein the extruded mixture comprises one or more radioisotopes suitable for radiation therapy;

whereby, in addition to providing enhanced imaging properties, the extruded mixture also supplies radiation therapy to tissue in the vicinity of the extruded mixture.

23. A method as recited in claim 18, wherein the extruded mixture comprises one or more biologically active agents;

whereby, in addition to providing enhanced imaging properties, the extruded mixture also supplies an agent for modifying tissue in the vicinity of the extruded mixture.

24. A method as recited in claim 23, wherein said biologically active agent is selected from the group consisting of anti-infective, antibacterial, antimicrobial, antifungal, antiviral, anti-parasitic, anti-inflammatory, anti-angiogenic, analgesic and cytotoxic agents, beneficial hormones or other peptides, and other biological response modifiers.

25. A method as recited in claim 18, wherein the mixture is extruded in multiple streams from said mixer.

26. A method as recited in claim 18, wherein the marked area comprises the site of a removed cyst, the site of a removed abscess, the site of a vascular anastomosis, the site of a fracture repair, the site of a nerve anastomosis, the site of a gut anastomosis, the site of a bronchial anastomosis, or the site of an implanted tissue transplant.